Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/31/1999EP0904110A1 Nitric oxide donors capable of reducing toxicity from drugs
03/31/1999EP0904109A1 Targeting macromolecular prodrugs to t lymphocytes
03/31/1999EP0904107A1 Immunoglobin-like domains with increased half lives
03/31/1999EP0904106A1 Feline vaccines containing chlamydia psittaci and method for making the same
03/31/1999EP0904105A1 Novel compounds
03/31/1999EP0904104A1 Novel compounds
03/31/1999EP0904103A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE GLUTAMYL tRNA SYNTHETASE FAMILY
03/31/1999EP0904100A1 Receptor ligand-facilitated delivery of biologically active molecules
03/31/1999EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
03/31/1999EP0904097A2 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
03/31/1999EP0904095A1 Chimeric isoprenoid synthases and uses thereof
03/31/1999EP0904093A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma
03/31/1999EP0904092A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
03/31/1999EP0904089A1 Methods for sterilizing female mammals
03/31/1999EP0904088A1 Gas- or gel-filled silicone cushion for treatment of keloid and hypertrophic scars
03/31/1999EP0904087A1 Phosphatidic acid-comprising compositions
03/31/1999EP0904086A1 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
03/31/1999EP0904085A1 USE OF ESTROGEN TO MODIFY THE AMOUNT OF SEROTONIN TRANSPORTER OR ITS mRNA
03/31/1999EP0904084A1 Emergency contraceptive kit
03/31/1999EP0904083A1 Anesthetic method
03/31/1999EP0904082A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/31/1999EP0904081A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
03/31/1999EP0904080A1 Inhibitors of farnesyl-protein transferase
03/31/1999EP0904079A1 Antidiabetic agents
03/31/1999EP0904078A1 COMPOSITION COMPRISING A Katp CHANNEL INHIBITOR FOR USE IN THE TREATMENT OF HEMORRHAGIC SHOCK
03/31/1999EP0904077A2 Methods for the preparation of biphenyl isoxazole sulfonamides
03/31/1999EP0904076A1 Inhibitors of farnesyl-protein transferase
03/31/1999EP0904075A1 Method for treating viral infections
03/31/1999EP0904074A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases
03/31/1999EP0904073A1 Zwitterionic compositions and methods as biological response modifiers
03/31/1999EP0904072A1 Methods of treating immunopathologies using polyunsaturated fattyacids
03/31/1999EP0904071A1 Oral rehydration product comprising glutamine
03/31/1999EP0904070A1 The use of buckminsterfullerene for treatment of neurotoxic injury
03/31/1999EP0904069A1 Pla2 inhibitors of angiogenesis
03/31/1999EP0904068A1 A method for detection of potential co-antioxidants
03/31/1999EP0904067A1 Transdermally administered dextromethorphan as antitussive agent
03/31/1999EP0904064A1 Oral pharmaceutical compositions containing sex hormones
03/31/1999EP0904063A2 Microparticles
03/31/1999EP0904061A1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
03/31/1999EP0904060A1 Antifungal compositions with improved bioavailability
03/31/1999EP0904055A2 Buccal, non-polar spray or capsule
03/31/1999EP0904054A1 USE OF alpha-ALKYLGLUCOSIDES AND alpha-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS
03/31/1999EP0904042A1 Cosmetic composition for rejuvenation of skin without skin irritation
03/31/1999EP0904031A1 Cationic polymer/lipid nucleic acid delivery vehicles
03/31/1999EP0877733A4 Process for production of piperidine derivatives
03/31/1999EP0877025A4 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
03/31/1999EP0877024A4 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as an aesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
03/31/1999EP0799025B1 Intravaginal drug delivery devices for the administration of 17beta-oestradiol precursors
03/31/1999EP0788492B1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
03/31/1999EP0769933B1 Alcoholic moisturizing after shave lotion
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999EP0737185B1 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof
03/31/1999EP0733035B1 Tricyclic derivatives, pharmaceutical compositions containing them
03/31/1999EP0714395B1 Vasoconstrictive substituted dihydropyranopyridines
03/31/1999EP0660711B1 Novel use of inhibitors of phosphodiestersase iv
03/31/1999EP0659752B1 Antibacterial and anti-tumor epoxide derivate dc 114-a1
03/31/1999EP0643705B1 PROCESS FOR PRODUCING N-beta-g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,7,10-TETRAAZACYCLODODECANE AND N-beta-g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AND THEIR METAL COMPLEXES
03/31/1999EP0625158B1 Therapeutic nucleosides of the 2',3'-dideoxy-3'-fluoro-purine series
03/31/1999EP0619704B1 composition for treating tumors having high tyrosinase activity
03/31/1999EP0613480B1 Process for the preparation of cephem derivatives
03/31/1999EP0591378B1 Method of preventing and treating chemotherapy-induced alopecia
03/31/1999EP0591275B1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
03/31/1999EP0567514B1 A system for enhanced in-vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion of agents
03/31/1999CN1212723A Disinfecting compositions and process for disinfecting surfaces
03/31/1999CN1212706A Serine protease inhibitors
03/31/1999CN1212705A Serine protease inhibitors
03/31/1999CN1212704A Serine protease inhibitors
03/31/1999CN1212702A Triterpene derivatives and remedies for liver diseases
03/31/1999CN1212701A Oligonucleotide analogues
03/31/1999CN1212700A Novel erythromycin derivatives, method for preparing same, and use thereof as drug
03/31/1999CN1212698A Morphine and diamorphine salts of anionic non-narcotic analgesics of substituted carboxylic acid type
03/31/1999CN1212696A Pyrimido [5,4-d] pyrimidines, medicaments containing these componds, their use and process for their production
03/31/1999CN1212695A 4-amino pyrimidine derivates, medicament containing these compounds, their use
03/31/1999CN1212694A Pyrimido [5,4-D] pyrimidines, medicaments containing these compounds, their use and process for their production
03/31/1999CN1212692A Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
03/31/1999CN1212691A Tricyclic compound and its preparation and use
03/31/1999CN1212690A Novel piperidines derived from 1-(piperazin-1-yl) aryl (oxylamino) carbonyl/4-aryl-piperidine as selective 5-HTiD beta receptor antagonist
03/31/1999CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
03/31/1999CN1212685A Azole compounds endowed with antimycotic activity for human and veterinary use
03/31/1999CN1212684A 4-anilinoquinazoline derivatives
03/31/1999CN1212683A 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
03/31/1999CN1212682A Aminotetralin derivatives and composition and method of use thereof
03/31/1999CN1212633A Disinfecting compositions and processes for disinfecting surfaces
03/31/1999CN1212628A Method of promoting bone growth with hyaluronic acid and growth factors
03/31/1999CN1212627A Method for treating insomnia
03/31/1999CN1212626A Tablets containing 'beta'-lactam antibiotic and process for producing the same
03/31/1999CN1212625A Caffeine and clemastine for treating respiratory disorders
03/31/1999CN1212624A Slow-release pharmaceutical formulations containing mizolastin
03/31/1999CN1212623A Method for inducing death of neoplastic cells using piperazine oxirane derivatives
03/31/1999CN1212622A Use of antagnoist of PPAR-alpha and PPAR-gamma for treatment of syndrom X
03/31/1999CN1212621A Tracheal smooth muscle relaxant
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/31/1999CN1212605A Composition and its use as food supplement or for lowering lipids in serum
03/31/1999CN1212256A Quinolone-and naphthyridone-carboxylic acid derivatives
03/31/1999CN1212255A Biphenylsulfonyl cyanamides, process for their preparation, and their use as medicament
03/31/1999CN1212162A High efficiency ointment for curing beri-beri (tinea pedis)
03/31/1999CN1212151A Health-care products composition
03/31/1999CN1212150A Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in blood to reduce risk of athereosclerosis and vascular disease
03/31/1999CN1212149A Use of inhibitor of Na+/H+ exchanger for production of medicament
03/31/1999CN1042732C Method for preparing antimicrobial agent for animals
1 ... 6520 6521 6522 6523 6524 6525 6526 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 ... 7860